C-reactive protein as a marker for active coronary artery disease in patients with chest pain in the emergency room

Clinical Cardiology

Volumn 25, Issue 10, 2002, Pages 456-460

  Magadle, Rasmi ^a   Weiner, Paltiel ^a   Beckerman, Marinella ^a   Berar Yanay, Noa ^a  

^a HILLEL YAFFE MEDICAL CENTER   (Israel)

Author keywords

Atherosclerosis; C reactive protein; Cardiovascular disease; Chest pain; Emergency room; Inflammation

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; EMERGENCY WARD; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RELIABILITY; SAFETY; THORAX PAIN;

EID: 0036788571     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960251004     Document Type: Article

References (34)

1. Braunwald E: Heart Disease: A Textbook of Cardiovascular Medicine, 5th edition, p. 1332. Philadelphia: WB Saunders, 1997
2. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndrome. N Engl J Med 1992;326:242-250
3. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-809
4. Hendrix MGR, Daemen M, Bruggeman CA: Cytomegalovirus nucleic acid distribution within the human vascular tree. Am J Pathol 1991;138:563-567
5. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Marnninen V, Manttari M, Frick MH, Huttunen JK: Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116:273-278
6. Patel P, Mendall MA, Carrington D, Strachan DP, Leathan E, Molineaux N, Levy J, Blakeston C, Symour CA, Camm AJ: Association of Helicobacter-pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 1995;311:711-714
7. Pepys MB: Acute Phase Proteins in the Acute Response. London: Springer-Verlag, 1989
8. Pepys MB: The acute phase response and C-reactive protein. In Oxford Textbook of Medicine (Eds. Weatherall DJ, Ledingham JGG, Warrell DA). New York, N.Y.: Oxford University Press, 1996
9. De Beer FC, Hind DRK, Fox KM, Allan RM, Maseri A, Pepys MB: Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 1982;47:238-243
10. Moti T, Sasaki J, Kawagushi H, Handa K, Takada Y, Matsunaga A, Kono S, Arakawa K: Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J 1995;129:234-238
11. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC: C-reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study. Br Med J 1996;312:1061-1065
12. Heinrich J, Schulte H, Schönfeld R, Köler E, Assman G: Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemostas 1995;73:374-378
13. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A: The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424
14. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB: Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997;349:462-466
15. Oltrona L, Ardissimo D, Merlini PA, Spinola A, Chiodo F, Pezzano A: C-reactive protein elevation and early outcome in patients with unstable angina pectoris. Am J Cardiol 1997;80:1002-1006
16. Toss H, Lindhal B, Siegbahn A, Wallentin L: Prognostic influence of increased fibrinogen on C-reactive protein levels in unstable coronary artery disease: FRISC Study group: Fragmin during instability in coronary artery disease. Circulation 1997;96:4204-4210
17. Lindhal B, Toss H, Siegbahn A, Venge P, Wallentin L: Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease: FRISC Study group: Fragmin during instability in coronary artery disease. N Engl J Med 2000;343:1139-1147
18. Kuller LH, Tracy RP, Shaten J, Meilahn EN, for the MRFIT group: Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537-547
19. Earl SF, Wayne HG: Serum C-reactive protein and self-reported stroke: Findings from the Third National Health and Nutrition Examination Survey. Arterioscler Thromb Vasc Biol 2000;20:1052-1056
20. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercelloti GM: C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-520
21. Jacobijn G, Marianne CLS, Marijke F, Gerard JB, Rudi GJW: C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons. Arterioscler Thromb Vasc Biol 2000;20:1047-1051
22. Centers for Disease Control and Prevention: Plan and operation of the Third National Health and Nutrition Examination Survey. 1988-1994. Bethesda, Md.: National Center for Health Statistics, 1994. Vital Health Statistics 1(32). Series 1, No. 32
23. Abbot Laboratories Instruction Manual: Protein C-reactive TDx/TDxFLx. Abbot Laboratories, North Chicago, Ill.
24. Shine B, De Beer FC, Pepys MB: Solid phase radioimmunoassay for CRP. Clin Chim Acta 1981;117:13-23
25. Berk BC, Weintraub WS, Alexander W: Elevation of C-reactive protein in active coronary artery disease. Am J Cardiol 1990;65:168-172
26. Kushner I, Broder ML, Karp D: Control of the acute phase response: Serum C-reactive protein kinetics after acute myocardial infraction. J Clin Invest 1978;61:235-242
27. Abdelmouttaleb I, Danchin N, Ilardo C, Aimone-Gastin I, Angioi M, Lozniewsli A, Loubinoux J, Le Faou A, Gueant JL: C-reactive protein and coronary artery disease: Additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999;137:346-351
28. Biasucci LM, Vitelli A, Liuzzo G, Altamura A, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A: Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-877
29. Dinarello C: Biologic basis for interleukin-6 in disease. Blood 1996;87:2095-2147
30. Pepys MB, Baltz ML: Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxin) and serum amyloid A protein. Adv Immunol 1983;334:141-212
31. Lagrand WK, Visser CA, Hermens WT, Niessen HN, Verheugt FW, Wolbink GJ, Hack CE: C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon? Circulation 1999;100:96-102
32. Lüscher TF, Boulanger CM, Yang Z, Noll G, Dohi Y: Interaction between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 1993;87(suppl):V36-V44
33. Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Limores E, Pauget JM, Sabharwal SC, Chesler E, Demots H: Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983;309:396-403
34. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammatio, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979